Controversy exists over optimal management of low-risk differentiated thyroid cancer. This
controversy occurs in all aspects of management, including surgery, use of radioactive …

Background. The treatment of differentiated thyroid cancer refractory to radioactive iodine
(RAI) had been hampered by few effective therapies. Recently, tyrosine kinase inhibitors …

Context Thyroid cancer incidence increased with the greatest change in adults aged≥ 65
years. Objective To determine the relationship between area-level use of imaging and …

Background: In most staging systems, 45 years of age is used to differentiate low risk thyroid
cancer from high risk thyroid cancer. However, recent studies have questioned both the …

Purpose Patient age is considered to play a unique prognostic role in papillary thyroid
cancer (PTC), with a distinct staging dichotomization at 45 years of age. This is based on …

Background: Little is known about cancer-related worry in thyroid cancer survivors with
favorable prognosis. Methods: A diverse cohort of patients diagnosed with differentiated …

Background: Management of patients with advanced medullary thyroid cancer (MTC)
remains a therapeutic challenge. The multi-tyrosine kinase inhibitors (TKIs) vandetanib and …

Objective Thyroid carcinoma (TC) is the most common endocrine tumor in the human body.
Papillary thyroid carcinoma (PTC) accounts for more than 80% of thyroid cancers. Accurate …

Background To the authors' knowledge, studies regarding risk perception among survivors
of thyroid cancer are scarce. Methods The authors surveyed patients who were diagnosed …

Context Age at diagnosis has been identified as a major determinant of thyroid cancer–
specific survival, with older patients being at higher risk for mortality, but the association of …